ArticleFuture oncology (London, England)2024

Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain.

Isabel Blancas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.